<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01769872</url>
  </required_header>
  <id_info>
    <org_study_id>KSC-MSCs-SPI</org_study_id>
    <nct_id>NCT01769872</nct_id>
  </id_info>
  <brief_title>Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury</brief_title>
  <official_title>Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biostar</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Biostar</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the efficacy and safety of autologous
      transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with
      spinal cord injury
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ASIA (American Spinal Injury Association) scale</measure>
    <time_frame>32 weeks</time_frame>
    <description>To evaluate the change of treated spinal cord before cell implantation and at 3 and 6 months post injection of MSCs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Magnetic Resonance Imaging</measure>
    <time_frame>32 weeks</time_frame>
    <description>To evaluate the change of treated spinal cord injury using Magnetic Resonance Imaging (MRI) at 3 and 6 months post injection of MSCs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MEP/SSEP</measure>
    <time_frame>32 weeks</time_frame>
    <description>To evaluate the change of treated spinal cord before cell implantation and at 3 and 6 months post injection of MSCs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ADL (activities of daily living)</measure>
    <time_frame>32 weeks</time_frame>
    <description>To evaluate the change of treated spinal cord before cell implantation and at 3 and 6 months post injection of MSCs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>32 weeks</time_frame>
    <description>To evaluate the change of treated spinal cord before cell implantation and at 3 and 6 months post injection of MSCs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ODI (Oswestry Disability Questionnaire)</measure>
    <time_frame>32 weeks</time_frame>
    <description>To evaluate the change of treated spinal cord before cell implantation and at 3 and 6 months post injection of MSCs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of Adverse Events</measure>
    <time_frame>32 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>Autologous Adipose Tissue derived MSCs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Autologous Adipose Tissue derived MSCs Transplantation</intervention_name>
    <description>Intravenous injection of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 2x10e8 cells / 20mL Intrathecal injection of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 5x10e7 cells / 2mL Into a spinal cord injection of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 2x10e7 cells / 1mL</description>
    <arm_group_label>Autologous Adipose Tissue derived MSCs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who understand and sign the consent form for this study

          -  Age : 19-70

          -  Clinical diagnosis of spinal cord injury(American Spinal Injury Association[ASIA]
             Impairment Scale[AIS] grade A or B or C)

          -  Duration of injury : &gt; 3 month

        Exclusion Criteria:

          -  Subjects who must put on a respirator

          -  Subjects who had malignant tumor within 5 years

          -  Subjects with a infectious disease include HIV and hepatitis

          -  Subjects who injured brain or spinal cord before spinal cord injury

          -  Subjects with anemia or thrombocytopenia

          -  Subjects with angina pectoris, myocardial infarction, cardiomyopathy, occlusive
             disease, chronic renal failure, glomerular disease and chronic obstructive pulmonary
             disease

          -  Subjects with congenital or acquired immunodeficiency disorders

          -  Patients with clouded consciousness or speech disorder

          -  treat with cytotoxic medications(immunosuppressive drug, corticosteroid and cytotoxic
             drug) during clinical trials

          -  participating another clinical trials within 3 months

          -  other serious disease or disorder that could seriously affect ability to participate
             in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tai-Hyoung Cho, M.D. &amp; Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Anam Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2013</study_first_submitted>
  <study_first_submitted_qc>January 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2013</study_first_posted>
  <last_update_submitted>August 1, 2016</last_update_submitted>
  <last_update_submitted_qc>August 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

